You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
|
|---|---|
| Published in |
Lancet Oncology, July 2013
|
| DOI | 10.1016/s1470-2045(13)70272-9 |
| Pubmed ID | |
| Authors |
József Zsiros, Laurence Brugieres, Penelope Brock, Derek Roebuck, Rudolf Maibach, Arthur Zimmermann, Margaret Childs, Daniele Pariente, Veronique Laithier, Jean-Bernard Otte, Sophie Branchereau, Daniel Aronson, Arun Rangaswami, Milind Ronghe, Michela Casanova, Michael Sullivan, Bruce Morland, Piotr Czauderna, Giorgio Perilongo, for the International Childhood Liver Tumours Strategy Group |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 33% |
| Spain | 2 | 22% |
| France | 1 | 11% |
| Mexico | 1 | 11% |
| India | 1 | 11% |
| Unknown | 1 | 11% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 78% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 178 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 26 | 14% |
| Researcher | 22 | 12% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Postgraduate | 15 | 8% |
| Student > Master | 15 | 8% |
| Other | 48 | 27% |
| Unknown | 38 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 99 | 55% |
| Biochemistry, Genetics and Molecular Biology | 9 | 5% |
| Psychology | 5 | 3% |
| Agricultural and Biological Sciences | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 15 | 8% |
| Unknown | 45 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2013.
All research outputs
#7,123,410
of 26,017,215 outputs
Outputs from Lancet Oncology
#3,825
of 6,958 outputs
Outputs of similar age
#55,770
of 208,920 outputs
Outputs of similar age from Lancet Oncology
#38
of 134 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 6,958 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,920 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.